Significance of targeting DNMT3A mutations in AML.

Ann Hematol · 2025 · PMC12031811 · PMID 39078434

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

FLT3 and NPM1 mutations lead to differential survival in patients with DNMT3A mutations and the observation of differentially expressed miRNAs, which may be significant for prognosis [ 114 ].

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.